DEVELOPMENT OF PEPTIDE-BASED IMMUNOTHERAPEUTIC FOR AIDS
IC Name
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
-
Activity
U19
-
Administering IC
AI
-
Application Type
5
-
Direct Cost Amount
-
Indirect Cost Amount
-
Total Cost
-
Sub Project Total Cost
-
ARRA Funded
-
CFDA Code
856
-
Ed Inst. Type
-
Funding ICs
-
Funding Mechanism
-
Study Section
SRC
-
Study Section Name